IMC Chicago LLC Buys New Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH)

IMC Chicago LLC bought a new stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 10,383 shares of the company’s stock, valued at approximately $896,000.

Several other institutional investors have also recently added to or reduced their stakes in PPH. Mirae Asset Global Investments Co. Ltd. boosted its position in VanEck Pharmaceutical ETF by 51.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 248,473 shares of the company’s stock valued at $23,565,000 after buying an additional 84,273 shares during the period. Thrivent Financial for Lutherans boosted its position in VanEck Pharmaceutical ETF by 33.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 234,890 shares of the company’s stock valued at $22,322,000 after buying an additional 59,025 shares during the period. Miller Investment Management LP boosted its position in VanEck Pharmaceutical ETF by 13.4% in the 3rd quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock valued at $19,722,000 after buying an additional 24,446 shares during the period. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management boosted its position in VanEck Pharmaceutical ETF by 117.4% in the 4th quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 200,000 shares of the company’s stock valued at $17,256,000 after buying an additional 108,000 shares during the period. Finally, Adamsbrown Wealth Consultants LLC boosted its position in VanEck Pharmaceutical ETF by 102.3% in the 4th quarter. Adamsbrown Wealth Consultants LLC now owns 149,631 shares of the company’s stock valued at $12,910,000 after buying an additional 75,659 shares during the period.

VanEck Pharmaceutical ETF Stock Down 0.2 %

Shares of PPH stock opened at $89.18 on Tuesday. VanEck Pharmaceutical ETF has a 52 week low of $84.48 and a 52 week high of $99.51. The stock has a market capitalization of $556.48 million, a PE ratio of 21.04 and a beta of 0.72. The firm has a 50 day moving average of $87.74 and a two-hundred day moving average of $91.69.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently disclosed a dividend, which was paid on Monday, December 30th. Stockholders of record on Friday, December 27th were given a dividend of $0.411 per share. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date of this dividend was Friday, December 27th.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.